Jildaz Caroff, Laurent Aubert, Cécile Lavenu-Bombled, Samy Figueiredo, Kamelia Habchi, Jonathan Cortese, Francois Eugene, Julien Ognard, Florence Tahon, Géraud Forestier, Heloise Ifergan, François Zhu, Jean-Francois Hak, Anthony Reyre, Morgane Laubacher, Abdoulaye Traore, Jean Philippe Desilles, Imad Derraz, Ricardo Moreno, Marc Bintner, Guillaume Charbonnier, Anthony Le Bras, Louis Veunac, Florent Gariel, Hocine Redjem, Jacques Sedat, Guillaume Tessier, Victor Dumas, Maxime Gauberti, Cyril Chivot, Arturo Consoli, Nicolas Bricout, Titien Tuilier, Alexis Guedon, Raoul Pop, Pierre Thouant, Guillaume Bellanger, Riccardo Zannoni, Sebastien Soize, Johann Sebastian Richter, Olivier Heck, Cristian Mihalea, Julien Burel, Jean-Baptiste Girot, Eimad Shotar, Sebastian Gazzola, Gregoire Boulouis, Basile Kerleroux
BACKGROUND: Neurointerventionists lack guidelines for the use of antithrombotic therapies in their clinical practice; consequently, there is likely to be significant heterogeneity in antithrombotic use between centers. Through a nationwide survey, we aimed to obtain an exhaustive cross-sectional overview of antithrombotic use in neurointerventional procedures in France. METHODS: In April 2021, French neurointerventional surgery centers were invited to participate in a nationwide 51-question survey disseminated through an active trainee-led research collaborative network (the JENI-RC)...
April 2023: Journal of Neurointerventional Surgery